GlassScriptPhysician profile
Chad Oliver
NPI 1841827854
$3,068.70
in general payments reported to CMS, 2019-2025
22 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $381 · 2023: $471 · 2024: $1,852 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,426 · Travel and Lodging: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,425.54 |
| Travel and Lodging | $1,011.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,199.20 | 2024 | |
| Ethicon US, LLC | $443.38 | 2021-2024 | Mega Soft, Evarrest, Surgiflo Hemostatic Matrix |
| Abiomed | $272.93 | 2023-2024 | Impella |
| Atricure, INC. | $207.13 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2), Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $198.89 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.32 | 2022-2024 | Jardiance |
| Amgen INC. | $66.84 | 2021-2022 | |
| Medtronic, INC. | $58.57 | 2022-2023 | Gia, Ligasure |
| Novartis Pharmaceuticals Corporation | $55.96 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $54.14 | 2022-2023 | |
| Davol INC. | $50.93 | 2021 | |
| Janssen Pharmaceuticals, INC | $49.57 | 2021-2023 | Xarelto |
| Novo Nordisk INC | $47.96 | 2022-2025 | Wegovy |
| Corcym INC | $33.08 | 2023 | Miami Instruments |
| Merck Sharp & Dohme LLC | $31.80 | 2023 | Verquvo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $31.71 | 2022 | |
| Amarin Pharma, INC. | $28.60 | 2021 | |
| Inspire Medical Systems, INC. | $21.68 | 2025 | Inspire |
| Genzyme Corporation | $20.66 | 2022 | |
| Amryt Pharma Holdings LTD | $15.20 | 2021 | |
| Stryker Corporation | $14.62 | 2024 | Na |
| Becton, Dickinson and Company | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.